Introduction
Reactive oxygen species (ROS) have recently become a focus of attention in study on signaling mechanism involved in various biological processes, including cell growth, apoptosis and angiogenesis (Lambeth, 2004) . In the case of nonphagocytic cells, a family of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) homologous to gp91 phox (Nox2) has been recognized as enzyme responsible for the nonmitochondrial induction of ROS. Nox enzymes are transmembrane proteins with binding sites for NADPH, FAD and heme, and catalyse the transfer of an electron to molecular oxygen to generate the superoxide anion with the aid of p22 phox (Lambeth et al., 2000) . Although Nox2 is predominantly expressed in phagocytes and engaged in host defense against microbiral infection (Bokoch, 1994) , Nox1 is abundant in colon (Suh et al., 1999) and appears to be involved in cell proliferation in response to epidermal growth factor (EGF) (Mitsushita et al., 2004) , Platelet-derived growth factor (PDGF) and angiotensin II (Lasse`gue et al., 2001) . Furthermore, uneven expression of Nox1 is associated with neoplastic transformation phenotypes including angiogenesis (Arbiser et al., 2002; Mitsushita et al., 2004) . Nox3 is originally isolated from fetal kidney (Cheng et al., 2001) and is also related to vestibular system of the inner ear (Paffenholz et al., 2004) . Nox4, found in kidney cortex (Geiszt et al., 2000) , plays possible roles in insulin action (Mahadev et al., 2004) , and Nox5, predominantly expressed in testis, spleen and lymph nodes, is implicated in Ca 2 þ -activated redox-dependent processes (Ba´nfi et al., 2001) . These observations suggest the specific biological role for each Nox family enzyme, perhaps reflecting its distinct regulatory system, cellular compartmentalization and expression pattern.
In addition to regulation of Nox activities by their subunits, alterations of the gene expression of the Nox isoforms could be critical for their activities. The activities of several Nox enzymes have been reported to be transcriptionally regulated. For example, the expression of Nox2 in mature phagocytes is induced by the inflammatory mediators including interferon-g (IFNg), where transcription of Nox2 involves the coordinate action of an Ets transcription factor PU.1 and IFNg regulatory factor 1 (Eklund et al., 1998) , and Nox2 is transcriptionally repressed in chronic granulomatous diseases (Newburger et al., 1988) . Similarly, expression of Nox1 mRNA is induced by the growth stimuli such as PDGF (Lasse`gue et al., 2001) and angiotensin II (Lasse`gue et al., 2001) . Some of human cancers including colon cancer are associated with increased levels of Nox1 expression (Geiszt et al., 2003) . However, none of the studies dissected the biochemical signaling pathway linking to the transcription of the Nox1 gene. We have recently found that Ras oncogene and EGF upregulate the Nox1 expression via the MEK-ERK phosphorylation cascade, and that elevated production of superoxide anion by Ras-induced Nox1 is indispensable for the Ras-transfomation phenotypes, including anchorage-independent growth and tumor formation in athymic mice (Mitsushita et al., 2004) . Thus, the transcriptional control of the Nox1 gene is most likely to be governed by the Ras/Raf/ MEK/ERK signaling pathway. However, the nature of the transcription factor involved remains to be determined and how oncogenic Ras signaling pathway upregulates Nox1 expression is unclear.
In the present study, we investigated the regulatory mechanism for the Nox1 transcription that is activated by Ras signaling. We identified the Ras-ERK-responsive element containing GATA-binding sites within the Nox1 promoter. GATA-6 was found to be essential for the transcription of Nox1. Furthermore, Ras upregulated the Nox1 mRNA expression through MEK-ERK-dependent phosphorylation of GATA-6. Our findings provide evidence that the Ras/ERK/ GATA-6 signaling pathway plays a critical regulatory role in the Nox1 transcription.
Results

Upregulation of Nox1 mRNA expression in CaCo-2 cells
We first examined the expression levels of Nox1 mRNA in various human cell lines by northern blotting (Figure 1a) . The 2.6-kb Nox1 mRNA was most highly expressed in the human colorectal adenocarcinoma cell line CaCo-2. In contrast, little expression of Nox1 mRNA was detected in the human colorectal adenocarcinoma cell line LoVo, myeloid leukemic cell line HL-60, T-cell line Jurkat and pancreatic carcinoma cell line PANC-1. Because we previously demonstrated that Nox1 gene expression is induced by activation of Ras (Mitsushita et al., 2004) , we tried to determine whether a high expression of Nox1 mRNA is accompanied by Ras activation in CaCo-2 cells. To this end, the activation state of endogenous Ras was evaluated by affinity precipitation of Ras-GTP complexes with Raf-1 RBDimmobilized resins (Figure 1c) . The elevated level of Ras activation was observed in CaCo-2 cells compared with the other cells examined. Thus, the elevated expression of Nox1 mRNA appeared to correlate with activation of endogeneous Ras, which is consistent with our previous observation that activation of the Ras/Raf/MEK/ERK signaling pathway results in transcriptional activation of Nox1 gene (Mitsushita et al., 2004) .
Characterization of the functional Nox1 promoter by deletion analysis of reporter constructs
The human Nox1 5 0 -flanking region was isolated. The restriction map of the 5 0 region encompassing the first exon is shown in Figure 2 . To determine the regions essential for the Nox1 promoter activity, the Nox1 genomic fragments with 5 0 -deletions were cloned into the reporter plasmid pGL-Basic. The reporter constructs containing nt À4008 (pGLNP-4008), nt À2594 (pGLNP-2594), nt À1415 (pGLNP-1415), nt À321 (pGLNP-321), nt À100 (pGLNP-100) and nt þ 1 (pGLNP0) were transiently transfected into CaCo-2 cells. Cell extracts were prepared 48 h after transfection and subjected to the relative luciferase activity assay. As shown in Figure 2 , pGLNP-1415 and pGLNP-321 constructs exhibited moderate transcriptional activities (20.0 and 27.6% of SV40 promoter, respectively), whereas the activity of pGLNP-100 was markedly reduced to the basal level. This indicates that a positive cis-element was mapped to the region between nt À321 and À100 of the Nox1 promoter.
Ras/ERK signaling enhances the Nox1 promoter activity Because the increased expression of Nox1 mRNA closely correlated with increased activation of Ras in CaCo-2 cells (Figure 1 ), we therefore examined the (Figure 3a) . These results indicate that the Ras/ERK signaling efficiently enhanced the Nox1 promoter activity, and that the region between nt À321 and À1 contained the Ras/ERK signaling-responsive element.
To further confirm the involvement of the Ras/ERK signaling in the regulation of the Nox1 promoter activity, we investigated the effects of the protein kinase inhibitors and activator on the Nox1 promoter activity (Figure 3b ). Pretreatment of CaCo-2 cells with PD98059 (an MEK inhibitor; 100 mM) for 12 h significantly reduced the Nox1 promoter activity. In contrast, wortmannin (a phosphoinositide 3-kinases (PI 3-kinase inhibitor, 83 nM) and phorbol 12-myristate 13-acetate (PMA; a protein kinase C activator, 83 ng/ml) did not affect the Nox1 promoter activity. These data also support our speculation that the Ras/ERK signaling stimulated the Nox1 promoter activity.
Ras/ERK signaling enhances binding of nuclear proteins to GATA-binding sites-containing region As demonstrated above, the portion between nt À321 and À1 of the Nox1 5 0 -flanking region was sufficient to induce the maximum level of Nox1 transcription and contained the Ras/ERK signaling-responsive element. Furthermore, predicted binding consensus sequences for transcription factors C/EBP (nt À248 to À236), AML-1 (nt À243 to À238 and À33 to À28), GATA factors (nt À151 to À147 and À114 to À110) and Ets1 (nt À72 to À63) were found in this region (Figure 4a ). To test whether nuclear proteins binding to the 5 0 -flanking delimited region are regulated by the Ras/ERK signaling, nuclear extracts were prepared from CaCo-2 cells transfected with the control, activated Ras and activated MEK expression vectors, and the DNA-binding activity was analysed by electrophoretic mobility shift assay (EMSA) using a 32 P-labeled probe À321/À1 (corresponding to nt À321 to À1). As shown in Figure 4b , formation of the protein-DNA complex was observed with the nuclear extract from the control vectortransfected cells, and this complex formation was remarkably increased by the activated Ras and MEK transfections. Thus, the Ras/ERK signaling enhances binding of the nuclear proteins to the Nox1 5 0 -flanking region nt À321 to À1.
To define the region responsible for the Ras/ERK signaling-induced activation of the Nox1 promoter, nuclear extracts from CaCo-2 cells transfected with activated Ras or MEK were analysed by EMSA with 32 P-labeled probes À321/À232 (corresponding to the region nt À321 to À232 containing C/EBP and AML-1 sites), À231/À100 (corresponding to the region nt À231 to À100 containing two GATA sites) and À100/À1 (corresponding to the region nt À100 to À1 containing Ets1, TATA box-like and AML-1 sites) (Figures 4c-d) . Formation of a complex on the probe À231/À100 was remarkably increased by the Ras and MEK transfections (Figure 4d ). In contrast, the complex formations on the probes À321/À232 (Figure 4c ) and À100/À1 Figure 4e ) did not show any significant change following the Ras and MEK transfections. These results indicate that the Ras/ERK signaling efficiently enhanced binding of the nuclear proteins to the region nt À231 to À100 of the Nox1 5 0 -flank. As the region nt À231 to À100 contained two putative GATA-binding sites, the GATA site-containing oligo probes À161/À136 and À125/À100 were tested for interaction with the nuclear proteins ( Figure 5a ). The complex formations on the GATA site-containing oligo probes À161/À136 (left panel) and À125/À100 (right panel) were significantly increased by the Ras and MEK transfections. Binding of the Ras/ERK signalingresponsive protein complexes was competed away by 200-fold excess of the unlabeled GATA site-containing oligonucleotides À231/À100, À161/À136 and À125/ À100, but not by 200-fold excess of the unlabeled oligonucleotide À255/À229 containing C/EBP and AML-1 sites ( Figure 5b ). In addition, the site-specific mutations of the two GATA sites resulted in approximately 80% reduction in the promoter activity and abolished Ras/MEK-dependent trans-activation in CaCo-2 cells (Figure 5c ). Taken together, these results indicate that the Ras/ERK signaling enhanced binding of nuclear proteins to the GATA sites (nt À161 to À136 and À125 to À100) of the Nox1 promoter region.
In vitro phosphorylation of nuclear proteins by ERK increases formation of GATA site-binding complexes To examine whether phosphorylation of nuclear proteins by activated ERK in vitro promotes their binding to the GATA sites of the Nox1 5 0 -regulatory region, nuclear extracts from CaCo-2 cells were preincubated in the kinase reaction mixture with or without MEKactivated ERK for 30 min, and the reaction products were then incubated in DNA-binding mixtures containing GATA probes À161/À136 and À125/À100 (Figure 5d ). In vitro phosphorylation of nuclear extracts by ERK remarkably increased binding of a protein complex to the GATA site-containing probes À161/ À136 and À125/À100 as compared to that without phosphorylation. The increased complex formation was specifically competed away by 200-fold excess of cold probes À161/À136 and À125/À100. Thus, the data suggest that phosphorylation of nuclear proteins by activated ERK directly increases their binding to the GATA sites (nt À161 to À136 and À125 to À100).
Detection of GATA-6 as a Ras/Raf/MEK/ERK signaling-responsive component of GATA site-binding complexes As CaCo-2 cells are known to express several ten times higher levels of GATA-6 mRNA than that of GATA-4 and -5 (Gao et al., 1998) , we performed the supershift assay using anti-GATA-4 and -6 antibodies to determine whether GATA-4 and -6 proteins bind to the GATA sites (nt À161 to À136 and À125 to À100) of the Nox1 promoter region. As shown in Figure 6a , the upper parts of GATA site-binding complexes appeared when incubated with the anti-GATA-6 antibodies, whereas anti-GATA-4 antibodies exhibited no effects. To further confirm the fact that the GATA site-binding At 36 h after transfection, PD98059 (100 mM), wortmannin (83 nM) and phorbol 12-myristate 13-acetate (PMA) (83 ng/ml) were added to the culture and the culture continued for additional 12 h. The promoter activity was measured as the relative luciferase activity. Bars, ±s.e. of triplicate determinations.
complexes contain GATA-6, we electrophoretically eluted the protein-DNA complexes from gels after EMSA and probed them with anti-GATA-6 antibodies.
Immunoblotting analysis clearly revealed a 52-kDa protein band reactive with anti-GATA-6 antibodies, whereas no bands were detected in the samples from the corresponding control area of EMSA gels (Figure 6b ). Furthermore, in vivo binding of GATA-6 to chromatin encompassing the two GATA sites of the Nox1 promoter was confirmed by chromatin immunoprecipitation (ChIP) assays (Figure 6c ). These results indicate that GATA-6 is a component of protein complexes bound to the GATA sites of the Nox1 promoter. Phosphorylation of GATA-1, -2, -3 and -4 is known to modulate their DNA-binding and protein-protein interactions resulting in cell-and gene-specific transcriptions (Morimoto et al., 2000; Patient and McGhee, 2002; Yu et al., 2005) . Likewise, GATA-6 contains consensus ERK phosphorylation sites (PXS/TP: PYS 120 P, PYS 192 P and PMT 369 P) (Suzuki et al., 1996) . We therefore investigated whether GATA-6 is phosphorylated by ERK in response to upstream Ras activation signals in CaCo-2 cells. Anti-GATA-6 and control antibody immunoprecipitates from CaCo-2 cell extracts were subjected to the kinase reaction by incubating with or without MEK-activated ERK for 30 min (Figure 7a ). As expected, GATA-6 was phosphorylated efficiently by MEK-activated ERK but not by inactivated ERK. The major phosphoamino acid was phosphoserine.
To examine whether phosphorylation of GATA-6 was induced by the Ras/Raf/MEK/ERK signaling, CaCo-2 cells were transfected with activated Ras and activated MEK expression vectors, and metabolically labeled with [ 32 P]orthophosphate. Lysates were subjected to immunoprecipitation with anti-GATA-6 antibodies followed by phosphoamino acid analysis. As shown in Figure 7b , GATA-6 was phosphorylated at serine residue(s) in CaCo-2 cells, and this in vivo phosphorylation was remarkably enhanced by the activated Ras and MEK. Taken together, theses results demonstrate that GATA-6, as a component of GATA ERK phosphorylation site PYS 120 P of GATA-6 is essential for the trans-activation of the Nox1 promoter Our results indicate that serine residues of GATA-6 are selectively phosphorylated in response to Ras/ERK signling ( Figure 7 ). To determine which serine phosphorylation is responsible for Ras/ERK-dependent regulation of GATA-6, GATA-6 mutants having alanine in place of serine at 120 (S120A) or 192 (S192A) were created based on consensus ERK phosphorylation sites (PXSP: PYS 120 P and PYS 192 P) (Suzuki et al., 1996) and transfected into CaCo-2 cells along with a Nox1 reporter construct pGLNP-321 in combination with an empty vector, pcDNA3.1-H-RasV12 or pSRa-DA-MEK. Ectopic wild-type GATA-6 significantly P-labeled probe À161/À136 (containing a GATA site or À125/À100 (containing a GATA site) for 30 min at 4 1C. Electrophoretic mobility shift assay (EMSA) was performed as described under 'Materials and methods'. (b) Activated nuclear extracts from DA-MEK-transfected CaCo-2 cells were incubated with 32 P-labeled GATA probe À161/À136 or À125/À100 in the presence or absence of a 200-fold excess of the double-strand DNA competitors À231/ À100 (containing two GATA sites), 161/À136, À125/À100 and À255/À229 (containing C/EBP and AML-1 sites). EMSA was performed as described under 'Materials and methods'. (c) Site-specific mutation of GATA sites downregulates the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) 1 promoter activity and abolishes Ras/MEK/ERK signal-dependent transactivation. CaCo-2 cells were transiently transfected with a control reporter pGLNP0, a wild-type Nox1 promoter-luciferase reporter pGLNP-321 or a GATA sites-mutated reporter pGLNP-321 mtGATA (mutated nt À147 TTATC and À110 GATAA to TTAAG and CTTAA, respectively) in combination with pcDNA3.1, pcDNA3.1-H-RasV12 or pSRa-DA-MEK. At 48 h after transfection, luciferase activities were measured. The means ± s.e. of triplicate determinations are shown. (d) In vitro phosphorylation of nuclear extracts by ERK enhances formation of GATA site-binding complexes. Nuclear extracts (5 mg protein each) from CaCo-2 cells were preincubated in the kinase reaction mixture with or without MEK-activated ERK for 30 min at 30 1C. The nuclear extracts were then incubated in DNA-binding mixtures containing 32 P-labeled GATA probes À161/À136 or À125/À100 in the presence or absence of a 200-fold excess of cold competitor DNA À161/À136 or À125/À100, and subjected to EMSA.
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trans-activated the Nox1 promoter depending on Ras/MEK/ERK signaling, whereas the GATA-6 S120A mutant completely abolished the trans-activation activity and did not show Ras/MEK dependency ( Figure 8a ). Another site-directed mutant GATA-6 S192A maintained the activity almost comparable to that of P-labeled probe À161/À136 (containing a GATA site or À125/À100 (containing a GATA site). Supershift reactions were performed by incubating the nuclear extracts with 1 mg of immunoglobulin G (IgG) specific for GATA-4 and GATA-6. An antibody-induced supershift on electrophoretic mobility shift assay (EMSA) is indicated by arrow. (b) Immunoblot analysis of the GATA site-binding complexes. After EMSA with À161/À136 and À125/À100 GATA probes and autoradiography, the protein-DNA complex bands (Band) and corresponding control areas (Control) were excised from the gels and subjected to in-gel SDS equilibration followed by electrophoretic elution and concentration. After SDSpolyacrylamide gel electrophoresis (PAGE), the detection was performed by immunoblotting with anti-GATA-6 antibodies and ECL system. (c) In vivo binding of GATA-6 to the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) 1 promoter. Cross-linked chromatin prepared from CaCo-2 cells was sonicated and subjected to chromatin immunoprecipitations (ChIP) with anti-GATA-6 antibodies or preimmune serum (Control). Following DNA purification, samples were subjected to PCR with primers covering GATA sites (corresponding to Nox1 promoter nt À214 to À20). wild-type GATA-6. The trans-activation by ectopic wild-type GATA-6 was specifically reduced by an MEK inhibitor PD98059 but not by a PI 3-kinase inhibitor wortmannin. By contrast, the GATA-6 S120A mutant no longer exhibited the trans-activation activity and was not affected by susceptibility to an MEK inhibitor (Figure 8b) . Together, the results demonstrate that ERK-dependent phosphorylation of GATA-6 on serine À120 is essential for the trans-activation of the Nox1 promoter by GATA-6 in response to Ras/ERK signaling.
MEK/ERK
To determine whether the deregulation of GATA-6 has a biological effect on the growth of CaCo-2 cells, the cells were transfected with wild-type GATA-6 or a GATA-6 S120A mutant and subjected to cell proliferation assay. Overexpression of GATA-6 S120A significantly reduced the rate of cell growth, whereas wild-type GATA-6 enhanced it (Figure 8c ), suggesting that the Ras/ERK/GATA-6 signaling pathway, at least in part, is required for the mitogenic response of CaCo-2 cells.
Discussion
Clarification of the mechanism underlying the transcriptional control of Nox1 is important in the view that the intracellular pool of Nox1, together with the activation state of its regulatory subunits, is a critical limiting factor for the Nox1 activity. In the present study, we investigated the molecular mechanism that transduces the transcriptional response of Nox1 to activation of the Ras signaling pathway. Our results indicate that expression of Nox1 gene in colorectal adenocarcinoma cells is mediated by the GATA-6 transcription factor whose activity is enhanced by ERK-dependent phosphorylation in response to Ras activation. This is consistent with our previous finding that upregulation of Nox1 by Ras oncogene via the Raf/MEK/ERK pathway increases intracellular ROS generation, contributing to maintenance of Ras-induced malignant transformation phenotypes (Mitsushita et al., 2004) . The findings provide a new insight into the signaling mechanism involved in the Nox1 expression, whose aberrant control is possibly associated with some of human diseases such as neoplastic transformation (Geiszt et al., 2003) .
The GATA family of transcription factors contains a highly conserved DNA-binding domain that consists of two zinc-finger motifs and plays critical roles in regulation of tissue-specific gene expression. Although GATA-1, -2 and -3 are essential for the development and differentiation of hematopoietic cell lineage, GATA-4, -5 and -6 contribute to development and differentiation in endoderm or mesoderm-derived organs such as intestine and gut (Molkentin, 2000) . In relation to cancer development, GATA-6 is suggested to have oncogenic effect because of its increased expression in proliferating progenitor cells, whereas GATA-4 and -5 might display tumor suppressor-like properties because of their upregulation in terminal differentiation of intestinal epithelium (Gao et al., 1998) . In this regard, it is noteworthy that in vitro and in vivo GATA-6 binding sites were found at position À161 to À136 and À125 to À100 within the proximal Nox1 promoter region in colon cancer cells, and that GATA-6 functions as a trans-activator of the Nox1 promoter. This appears to be consistent with observations that GATA-6 is a prominently expressed in colorectal cancer, whereas GATA-4 and -5 are epigenetically silenced (Akiyama et al., 2003) . Indeed, site-specific mutations of both GATA sites downregulated the Nox1 promoter activity by 80% in our study, suggesting that GATA-6 is a major transcription factor for Nox1. In addition, our deletion analysis of the Nox1 promoter and EMSA showed that the Ras-ERK-responsive elements are confined to the two GATA site-containing regions. Moreover, supershift assay clearly demonstrated that the nuclear protein complexes at the two GATA-binding sites contain GATA-6.
One major new finding in our study is that the mechanism of GATA-6 regulation involves post-translational modification by Ras/ERK-dependent phosphorylation. Although a putative GATA-binding site in mouse Nox1 promoter was reported (Brewer et al., 2006) , the detailed regulatory mechanism of Nox1 expression and in vivo involvement of GATA-6 in the regulation of Nox1 promoter were not defined. Furthermore, no other study has revealed the phosphorylationdependent regulatory mechanism for GATA-6. Our conclusion can be drawn from the facts that overexpression of the dominant-active RasV12 or dominantactive MEK mutants enhanced GATA-6 binding to the Nox1 promoter, increasing the Nox1 promoter activity, and that PD98059 but not wortmannin or PMA inhibited the transcriptional activity of Nox1. Furthermore, GATA-6 was directly phosphorylated at serine residues by ERK, as determined by both in vivo and in vitro kinase assay and this phosphorylation was increased by RasV12 and the activated MEK (Figure 8a ). GATA-6 contains a consensus ERK phosphorylation sequence PXSP surrounding serine residues 120 and 192. We found that single mutation at serine À120 but not À192 abolished the transactivation activity of GATA-6, supporting the idea that phosphorylation of GATA-6 serine À120 by ERK is essential for activating the GATA-6 activity and thereby exerts a critical mediating role in the Ras-induced transcription of Nox1 gene. It is tempting to speculate that phosphorylation of GATA-6 modulate its affinity for regulatory domains of the Nox1 promoter. Alternatively, phosphorylation of GATA-6 on serine À120 may facilitate the interaction with other components of the nuclear protein complexes bound to GATA sites. Other members of the GATA transcription factor family have been shown to exist as phosphoproteins. For example, GATA-1 is phosphorylated in erythroid cells by ERK upon erythropoietin stimulation (HernandezHernandez et al., 2006) and GATA-4 is phosphorylated in cardiac myocytes by ERK/p38 MAPK in response to hypertrophic stimuli (Tenhunen et al., 2004) or ERK following hepatocyte growth factor stimulation (Kitta et al., 2003) . These phosphorylation events commonly activate the DNA-binding activity of the GATA family proteins. Our present findings add GATA-6 to the increasing list of the GATA family factors whose activities are regulated by phosphorylation reaction. Consensus ERK phosphorylation site PYS 120 P of GATA-6 is essential for the trans-activation of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) 1 promoter. (a) CaCo-2 cells were transiently transfected with a Nox1 promoterluciferase reporter pGLNP-321 together with an empty vector pcDNA3.1, a wild-type GATA-6 expression plasmid pME18S-hGATA-6, ERK phosphorylation sites-mutated GATA-6 expression plasmids (pcDNA3.1-hGATA-6-S120A and pcDNA3.1-hGATA-6-S192A), pcDNA3.1-H-RasV12 or pSRa-DA-MEK as indicated. At 48 h after transfection, the trans-activation of the Nox1 promoter was measured. The data (subtracted by the endogeneous GATA-6 activity) represent the means±s.e. of triplicate determinations. Expression of ectopic GATA-6 and its mutants was monitored by immunoblotting with anti-GATA-6 antibodies. (b) Effects of MEK and phosphoinositide 3-kinases (PI3K) inhibitors on the GATA-6 activity. At 36 h after transfection, 100 mM PD98059 and 83 nM wortmannin were added to the cultures and the culture continued for additional 12 h. The promoter activities induced by ectopic wildtype GATA-6 and GATA-6 S120A were measured. The data (subtracted by the endogeneous GATA-6 activity) represent the means±s.e. of triplicate determinations. Expression of ectopic GATA-6 and its mutant were monitored by immunoblotting. (c) Effects of overexpression of GATA-6 and its mutant on cell proliferation. CaCo-2 cells were transfected with GATA-6 and GATA-6 S120A and serum-starved for 18 h. Cell numbers were determined at indicated time points after refeeding with the 10% fetal bovine serum (FBS)-containing growth medium. Average cell numbers determined at each time point are shown with standard deviations in triplicate experiments.
Ras/ERK signaling upregulates Nox1 gene expression Y Adachi et al 1996) and PU.1 (Eklund et al., 1998) , either positively or negatively, control the transcription of Nox2 in myeloid cells and neutrophils, respectively. Cyclic AMP response element-binding proteins have been found to be responsible for acid-induced expression of Nox5-S in barrett esophagel adenocarcinoma cells (Fu et al., 2006) . Our present studies define the essential regulatory role of GATA-6 in the transcription of Nox1 in colorectal epithelium. Recently, a nuclear factor (NF)-kB inhibitor, pyrrolidine dithiocarbamate has been shown to block flora-dependent induction of Nox1 expression and ROS production in colon cancer cells, implying the involvement of NF-kB in the Nox1 transcription (Kawahara et al., 2004) . However, no direct evidence was provided for the increased DNA binding of NF-kB to the Nox1 promoter in response to the ligand stimulation, which makes this observation need to be further assessed. Transcriptional control of the genes encoding the Nox family varies depending on Nox isoforms and cell types, possibly reflecting their tissuespecific functional roles. Thus, one issue is how general the transcriptional regulation of Nox1 by the MEK/ ERK/GATA-6 pathway might be. It would be of particular interest to test this possibility with angiotensin II-induced Nox1 expression in vascular smooth muscle cells, because induction of Nox1 transcription was accompanied by activation of ERK (Lasse`gue et al., 2001) .
In summary, we for the first time provide evidence that ERK connects the Ras signaling cascade to the GATA-6 transcription factor, leading to transcriptional control of Nox1. This signaling pathway may, at least in part, participate in cell growth control in certain types of colon cancer cells, because an ERK-phosphorylation defective mutant GATA-6 S120A suppressed the growth of CaCo-2 cells. The discovery would facilitate our understanding of previously uncharacterized cell transformation mechanism by Ras oncogene.
Materials and methods
Cell culture
The human colorectal adenocarcinoma cell line CaCo-2 was maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% fetal bovine serum (FBS) at 37 1C in humidified air with 5% CO 2 (Fang et al., 2001) . The human colorectal adenocarcinoma cell LoVo and the human pancreatic carcinoma cell line PANC-1 were maintained in DMEM supplemented with 10% FBS (Debruyne et al., 2003; Fensterer et al., 2004) . The human myeloid leukemic cell line HL-60 and the T-cell line Jurkat were maintained in RPMI 1640 medium supplemented with 10% FBS (Adachi et al., 1994) .
Northern blotting analysis
Total cellular RNAs were isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA), and the aliquots (10 mg per lane) were subjected to a 1% agarose formaldehyde gel electrophoresis, and transferred to a nylon membrane. Full-length human Nox1 cDNA (2.6 kb) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 1.27-kb PstI fragment from pRGAPDH13) as probes were labeled with [a-32 P]dCTP (220 TBq/mmol; GE Healthcare, Buckinghamshire, UK) using a Megaprime random primer labeling kit (GE Healthcare) (Chu et al., 2001) . Hybridization was performed at 65 1C for 3 h.
Measurement of Ras activation
Activation of endogeneous Ras was assayed by affinity precipitation of Ras-GTP using a Ras activation assay kit (Upstate Biotechnology, Lake Placid, NY, USA). Cells were washed with phosphate-buffered saline (PBS) and lysed in 0.5 ml of lysis buffer (25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-NaOH, 150 mM NaCl, 1% Igepal CA-630, 10 mM MgCl 2 , 1 mM EDTA, 10% glycerol, pH 7.5). Lysates were centrifuged at 12 000 r.p.m. for 5 min in a microcentrifuge. 10 ml of Raf-1 RBD-conjugated agarose beads was added to the lysates at 4 1C for 30 min, and the proteins retained to beads were separated by SDS-polyacrylamide gel electrophoresis (PAGE) prior to transfer to a nitrocellulose membrane. The protein blots were subjected to immunoblotting with rabbit anti-Ras antibodies, followed by horseradish peroxidase-coupled goat anti-rabbit immunoglobulin G (IgG) antibodies and ECL development (GE Healthcare).
Plasmid constructions
The HindIII/NcoI (nt À4008 to þ 205), SmaI/NcoI (nt À2594 to þ 205), BalI/NcoI (nt À1415 to þ 205), NheI/NcoI (nt À321 to þ 205) and HindIII/NcoI (nt þ 1 to þ 205) fragments of the 5 0 -regulatory region of the human Nox1 gene were generated by PCR using corresponding specific primers with human T-cell line Jurkat genomic DNA and inserted into the upstream of the firefly luciferase gene of the reporter plasmid pGL3-Basic (Promega, Madison, WI, USA) to generate pGLNP-4008, pGLNP-2594, pGLNP-1415, pGLNP-321 and pGLNP0, respectively. A GATA sites-mutated reporter pGLNP-321 mtGATA (mutated nt À147 TTATC and À110 GATAA to TTAAG and CTTAA, respectively) was prepared by using QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA). Site-directed mutants of human GATA-6, pcDNA3.1-hGATA-6-S120A (mutated PYS 120 P to PYA 120 P) and pcDNA3.1-hGATA-6-S192A (mutated PYS 192 P to PYA 192 P) were generated by overlap extension method with a slight modification. Activated Ras expression plasmid pcDNA3.1-H-RasV12, activated MEK expression plasmid pSRa-dominant-active (DA)-MEK (LA-SDSE mutant), GST-MEK expression plasmid pGST-Xenopus MEK, GST-ERK plasmid pGST-Xenopus ERK and human GATA-6 expression plasmid pME18S-hGATA-6 were generous gifts from Dr J Downward, Dr E Nishida and Dr M Maeda, respectively.
Transfections and luciferase reporter assays CaCo-2 cells were transfected in combination with 1 mg of each luciferase reporter and 1 mg of each expression plasmid by using LipofectAMINE2000 (Invitrogen). At 24 h after transfection, the cells were stimulated with 20% FBS for 24 h, and subsequently treated with 100 mM PD98059, 83 nM wortmannin or 83 ng/ml PMA for 12 h. Then, cells were extracted and cell lysates (25 ml) were assayed for luciferase activity using Luciferase Assay System (Promega) according to the manufacturer's instructions.
Electrophoretic mobility shift assays Nuclear extracts were prepared from CaCo-2 cells according to the previously described method (Chu et al., 2001 ). Cells were harvested by scraping, washed with ice-cold PBS, resuspended
